What Happened?
Fort Washington, PA-based Aurinia Pharmaceuticals Appointed Charlie Rowland as President and Chief Executive Officer
About the Company
Aurinia is a global clinical stage biopharmaceutical company focused on developing and commercializing innovative products to treat identifiable patient populations that are suffering from serious diseases with a high unmet medical need. The company is headquartered in Victoria, BC and focuses its development efforts globally.
About the Person
Charlie Rowland is President and Chief Executive Officer at Aurinia Pharmaceuticals. Previously, Charlie held various senior HR leadership roles in the industry.
Info Source
News
Short Profile